Lv1
48 积分 2024-08-24 加入
Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Secukinumab: Dose Exploration in Pediatric Patients with Plaque Psoriasis
2天前
已关闭
Physiologically based pharmacokinetic model of brivaracetam to predict the exposure and dose exploration in hepatic impairment and elderly populations
2天前
已关闭
Physiologically based pharmacokinetic model of brivaracetam to predict the exposure and dose exploration in hepatic impairment and elderly populations
2天前
已完结
Determination of sunitinib and its active metabolite, N-desethyl sunitinib in mouse plasma and tissues by UPLC-MS/MS: assay development and application to pharmacokinetic and tissue distribution studies
18天前
已关闭
In vitro and in vivo pharmacokinetic characterization of mavacamten, a first-in-class small molecule allosteric modulator of beta cardiac myosin
1个月前
已完结
A pharmacokinetic-pharmacodynamic model of d-sotalol Q-Tc prolongation during intravenous administration to healthy subjects
1个月前
已完结
Effects of 27 CYP3A4 protein variants on saxagliptin metabolism in vitro
1个月前
已关闭
Mavacamten, a First-in-Class Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy
2个月前
已完结
Effects of CYP2C19 inhibitors on mavacamten pharmacokinetics in rats based on UPLC-MS/MS
2个月前
已关闭
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
3个月前
已完结
皖公网安备34019202002308
